---
title: "Hourly Market Review - Mar 3, 2025 12 PM"
description: "Movers of the hour include Castellum up 29.17% at $1.40, OCFT up 23.73% at $6.80, and Aldeyra Therapeutics up 21.23% at $6.20. Nvidia received multiple upgrades from analysts, with target prices raise"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/230356116.md"
published_at: "2025-03-03T17:00:46.000Z"
---

# Hourly Market Review - Mar 3, 2025 12 PM

> Movers of the hour include Castellum up 29.17% at $1.40, OCFT up 23.73% at $6.80, and Aldeyra Therapeutics up 21.23% at $6.20. Nvidia received multiple upgrades from analysts, with target prices raised by firms like Rosenblatt, Needham, and B of A Securities, reaching up to $220. Amazon.com was downgraded by Wells Fargo with a target price decrease to $203.

**Movers of the hour:**  

Castellum is up 29.17% at $1.40.

OCFT is up 23.73% at $6.80.

Aldeyra Therapeutics is up 21.23% at $6.20.

Allegro is up 20.09% at $26.78.

Atlantic is up 18.72% at $2.51.

**Here are the top stocks upgraded by Wall Street analyst:**

Nvidia has received a rating of Strong Buy from Rosenblatt with target price increased to $220 from $220.

Nvidia has received a rating of Strong Buy from Needham with target price increased to $160 from $160.

Nvidia has received a rating of Strong Buy from B of A Securities with target price increased to $200 from $190.

Nvidia has received a rating of Buy from Morgan Stanley with target price increased to $162 from $152.

Nvidia has received a rating of Strong Buy from Truist Securities with target price increased to $205 from $204.

Nvidia has received a rating of Strong Buy from Benchmark with target price increased to $190 from $190.

Nvidia has received a rating of Buy from Cantor Fitzgerald with target price increased to $200 from $200.

Nvidia has received a rating of Neutral from DA Davidson with target price increased to $135 from $135.

Nvidia has received a rating of Strong Buy from Rosenblatt with target price increased to $220 from $220.

Amazon.com has received a rating of Neutral from Wells Fargo with target price dropped to $203 from $207.

### Related Stocks

- [ALDX.US - Aldeyra Therap](https://longbridge.com/en/quote/ALDX.US.md)
- [WFC.US - Wells Fargo](https://longbridge.com/en/quote/WFC.US.md)
- [NVDA.US - NVIDIA](https://longbridge.com/en/quote/NVDA.US.md)
- [CTM.US - Castellum](https://longbridge.com/en/quote/CTM.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| As Meta and Nvidia Announce a Huge, Multi-Year Partnership, Which Is the Better Stock to Buy? | As Meta and Nvidia Announce a Huge, Multi-Year Partnership, Which Is the Better Stock to Buy? | [Link](https://longbridge.com/en/news/276450266.md) |
| Citi Is Hot on Nvidia Ahead of February 25. Should You Buy NVDA Stock Now? | Citi Is Hot on Nvidia Ahead of February 25. Should You Buy NVDA Stock Now? | [Link](https://longbridge.com/en/news/276246621.md) |
| Delhivery Builds AI-Powered Location Intelligence With Nvidia | Delhivery Ltd :DELHIVERY - BUILDS AI-POWERED LOCATION INTELLIGENCE WITH NVIDIA | [Link](https://longbridge.com/en/news/276304010.md) |
| Nvidia stock retail traders are getting bearish days ahead of Q4 print: What's causing jitters? | Nvidia's stock sentiment among retail traders has turned bearish ahead of its Q4 earnings report, influenced by market w | [Link](https://longbridge.com/en/news/276412751.md) |
| Readystate Asset Management LP Sells 288,480 Shares of Celldex Therapeutics, Inc. $CLDX | Readystate Asset Management LP has significantly reduced its stake in Celldex Therapeutics, Inc. by 86.1%, selling 288,4 | [Link](https://longbridge.com/en/news/276326472.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
